Valuation Orion Oyj

Stocks

Market Closed - Nasdaq Helsinki 20:00:00 05/10/2026 +04			Pre-market 10:17:11
80.85 ^EUR	+0.06%		81.35	+0.62%

10-05	Orion Corporation (Orion Pharma) Announces First Patient Dosed In BICIDES Phase 1/2 Clinical Trial Evaluating ODM-216	CI
10-05	Orion Doses First Patient in Early-stage Trial of Potential Anticancer Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	5,119	7,179	5,509	6,005	8,944	11,341	-	-
Change	-	40.25%	-23.26%	8.99%	48.95%	26.8%	-	-
Enterprise Value (EV) ¹	5,010	7,060	5,603	6,126	9,088	11,251	11,008	10,738
Change	-	40.91%	-20.65%	9.35%	48.35%	23.8%	-2.16%	-2.45%
P/E	26.5x	20.6x	25.5x	18.2x	17.9x	20.1x	17x	15.3x
PBR	6.86x	7.91x	6.19x	5.98x	6.97x	7.09x	5.71x	4.68x
PEG	-	0.3x	-0.7x	0.3x	0.3x	1.6x	0.9x	1.3x
Capitalization / Revenue	4.92x	5.36x	4.63x	3.89x	4.73x	5.41x	4.78x	4.44x
EV / Revenue	4.81x	5.27x	4.71x	3.97x	4.81x	5.37x	4.64x	4.2x
EV / EBITDA	17.3x	14.5x	17.2x	12x	13.2x	14.6x	12.1x	10.7x
EV / EBIT	20.6x	16.1x	20.4x	14.7x	14.4x	15.9x	13.1x	11.5x
EV / FCF	38.5x	21.7x	105x	29.7x	41.5x	22.8x	21.3x	17.1x
FCF Yield	2.6%	4.6%	0.95%	3.37%	2.41%	4.38%	4.69%	5.85%
Dividend per Share ²	1.5	1.6	1.62	1.64	1.8	1.945	2.168	2.47
Rate of return	4.11%	3.12%	4.13%	3.83%	2.83%	2.41%	2.68%	3.06%
EPS ²	1.38	2.49	1.54	2.35	3.56	4.02	4.746	5.298
Distribution rate	109%	64.3%	105%	69.8%	50.6%	48.4%	45.7%	46.6%
Net sales ¹	1,041	1,341	1,190	1,542	1,890	2,097	2,373	2,557
EBITDA ¹	289.1	487.1	326.4	509.4	688.3	772	906.6	1,002
EBIT ¹	243.3	439.6	274.9	416.6	631.6	709.1	837.5	933.2
Net income ¹	193.8	349.5	216.8	329.9	500.3	565.6	668	746.2
Net Debt ¹	-108.3	-118.7	93.3	121.7	144.4	-89.76	-333	-603.1
Reference price ²	36.52	51.24	39.27	42.78	63.65	80.85	80.85	80.85
Nbr of stocks (in thousands)	140,563	140,202	140,351	140,501	140,693	140,366	-	-
Announcement Date	10/02/22	09/02/23	13/02/24	25/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ORION OYJ	20.11x	5.37x	14.57x	2.41%	12.71B
ELI LILLY AND COMPANY	32.46x	11.79x	23.8x	0.61%	1,019B
JOHNSON & JOHNSON	28.13x	6.24x	17.86x	2.11%	610B
ABBVIE INC.	33.64x	7.86x	16.24x	2.61%	470B
MERCK & CO., INC.	101.52x	5.7x	24.22x	2.45%	344B
ROCHE HOLDING AG	18.95x	4.61x	11.45x	2.87%	336B
NOVARTIS AG	19.74x	5.16x	12.75x	3.1%	266B
ASTRAZENECA PLC	19.84x	4.13x	11.77x	2.15%	241B
AMGEN INC.	25.45x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.74x	6.39x	24.95x	2.28%	179B
Average	25.61x	6.39x	16.95x	2.31%	369.55B
Weighted average by Cap.	31.21x	7.59x	18.52x	1.97%